Skip to Content

LP 607 (Temozolomide 140 mg)

Pill with imprint LP 607 is Blue & White, Capsule-shape and has been identified as Temozolomide 140 mg. It is supplied by Lotus Pharmaceutical Co., Ltd..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LP 607

Temozolomide

Imprint:
LP 607
Strength:
140 mg
Color:
Blue & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lotus Pharmaceutical Co., Ltd.
National Drug Code (NDC):
40051-0607

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide